Revolution Medicines (RVMD) Preferred Dividend Payments (2019 - 2020)
Revolution Medicines (RVMD) posted quarterly Preferred Dividend Payments of $2.2 million for Q1 2020, down 17.08% year-over-year from $2.7 million in Q2 2019, and down 47.8% quarter-over-quarter from $4.3 million in Q4 2019.
Powered by 
Analysis
Revolution Medicines (RVMD) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Revolution Medicines' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $2.2 million for Q1 2020.
- In Q1 2020, Preferred Dividend Payments fell 17.08% year-over-year to $2.2 million; the TTM figure through Dec 2020 stood at $2.2 million (down 84.41% YoY), while the FY2020 annual figure was $2.2 million, down 84.41% from the prior year.
- Preferred Dividend Payments for Q1 2020 stood at $2.2 million, down from $4.3 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $4.3 million in Q4 2019, with the low at $2.2 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 2.22 Mn |
| Dec 31, 2019 | 4.25 Mn |
| Sep 30, 2019 | 4.25 Mn |
| Jun 30, 2019 | 3.06 Mn |
| Mar 31, 2019 | 2.68 Mn |